When Apple prefects the process and uses it on a mass sale Peker projects that the will have spent 300 to 500 million. Now if they spend that much for only the CE part of the patents I would think you could give it a multiple of two or three for the rest.
Split the difference and say they spent 400. Multiply that by 3 ( medical, aerospace, and automotive should allow for this), and we have 1.2 billion dollars. Shares outstanding around 480 million and we get about 2.50 a share.
I'm not saying the IP is worth this now because it's not even close. I'm am saying I believe that once proven that in can mass produce while being cost effective we can see 2.50.
The knives aren't going to cut it ( I like puns!). I feel we are on are way and we just need to hang tight.
We certainly agree, that after 13 years from the IPO, this Company is not new news and the current PPS reality shows that expectations are not fueling this stock.
Only revenues yielding net profits is all that the market cares about.
Once profits kick in, then further expectations of growth based upon valid realistic forecasts can provide the multiples you are talking about.
As you and I know, multiples are not based upon zero based revenues.
News 
Market Data 
Discover 
AI
